Ambrx Biopharma, Inc.

Deep Track Capital, LP

Report date

12/31/2023

Quarter

2023 Q4

Filed

2/14/2024

Shares

3,710,412

Value ($000)

52,836

Weight

1.9%

2023 Q4 - 2023 Q4 (1 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2023 Q4	2/14/2024	52,836	1.9%	3,710,412	12/31/2023